Conquering Diseases

Study Of An Experimental Blood Test To Predict The Benefit Of Chemotherapy Following Surgery For Colon Cancer

Description

Seeking men and women who have early stage colon cancer that has been treated with surgery for a study of an experimental test using cancer cells in the blood to predict the benefit of chemotherapy.

Overview

Usually people whose early stage colon cancer is treated with surgery don't receive further treatment unless the cancer returns. In this study, participants will be randomly chosen to either have their blood tests analyzed immediately for cancer cells or analyzed later. Participants whose blood tests are analyzed immediately and show cancer cells will receive one of two chemotherapy treatments chosen by the participant and their doctor. All participants will receive regular checkups.

What we're hoping for

Evaluate a blood test that may help predict which early stage colon cancer patients would benefit from chemotherapy after having surgery.

Additional Information

ClinicalTrials.gov Identifier: NCT04068103

 Principal Investigator

Tasneem  Ali, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989